Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Daltonic, Zeiss Integrate Imaging Tools

NEW YORK (GenomeWeb News) – Bruker Daltonik and Carl Zeiss MicroImaging have integrated their respective molecular imaging and virtual imaging technologies for use in molecular histology research, Bruker said today.

The integration of Bruker's MALDI Molecular Imager and the Carl Zeiss' Virtual Slide Scanner will enable researchers to directly overlay microscopic images with molecular and spectral information in one software visualization tool, Bruker said. Previously, the company said, interpreting MALDI imaging data in pathology research required "repeated switching" between the MALDI molecular and microscopic images.

Sören-Oliver Deininger, a product specialist at Bruker Daltonics, said in a statement that the integration will "significantly accelerate clinical pathology research, particularly in oncology, where the untargeted molecular information is expected to reveal additional subtle changes in tissue that cannot be distinguished by traditional histology methods today."

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.